FIND Diagnostics - About the company
FIND Diagnostics is a funded company based in Geneva (Switzerland), founded in 2003. It operates as a Diagnostic tests for poverty-related diseases. FIND Diagnostics has raised an undisclosed amount in funding. The company has 333 active competitors, including 80 funded and 49 that have exited. Its top competitors include companies like Adaptive Biotechnologies, MeMed and HaystackAnalytics.
Company Details
FIND is a global non-profit organization engaged in the development, evaluation, and delivery of high-quality, affordable diagnostic tests for poverty-related diseases, including TB, malaria, HIV/AIDS, sleeping sickness, hepatitis C, Chagas disease, etc., as well as infectious diseases with outbreak potential, such as Ebola. FIND operates as a product development partnership with active collaborations with over 150 organizations including government ministries, academic centers, commercial entities, NGOs and PPPs. Intellectual property developed and owned by FIND is commercialized in partnership with commercial entities in a manner that ensures that benefits are passed on to patients in resource-poor settings, while distribution rights for high-income countries and the private sector in developing countries are retained by the industry partner.
- Website
- finddx.org
- Social
- Email ID
- *****@finddx.org
- Phone Number
- +41 **********
- Registered Address
- Flat No. 8, 9th Floor, Vijaya Building, 17 Barakhamba Road, Central Delhi, New Delhi, Delhi, India, 110001
Key Metrics
Founded Year
2003
Location
Geneva, Switzerland
Stage
Funding Raised
Latest Funding Round
Ranked
72nd among 333 active competitors
Employee Count
433 as on Apr 30, 2026
Similar Companies
Legal entities associated with FIND Diagnostics
FIND Diagnostics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS INDIA CIN: U73100DL2015NPL282471 , India, Active | Jul 07, 2015 | $2.81M (As on Mar 31, 2025) | - |
Sign up to download FIND Diagnostics' company profile
FIND Diagnostics's funding and investors
FIND Diagnostics has raised funding over 3 rounds. Its first funding round was on Sep 02, 2010. Its latest funding round was a Grant (prize money) round on Oct 01, 2022 for $*****. 1 investor participated in its latest round. FIND Diagnostics has 2 institutional investors.
Here is the list of recent funding rounds of FIND Diagnostics:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 01, 2022 | 1830540 | Grant (prize money) | 6293314 | 8674147 | 6260360 | 4195379 |
Jan 01, 2019 | 6925933 | Grant (prize money) | 2493531 | 2403296 | 1047946 | 7554319 |
Sep 02, 2010 | 3066663 | Grant (prize money) | 8499359 | 5863091 | 7319937 |
Access funding benchmarks and valuations. Sign up today!View details of FIND Diagnostics's funding rounds and investors
FIND Diagnostics' founders and board of directors
Founder? Claim ProfileFIND Diagnostics' employee count trend
FIND Diagnostics has 433 employees as of Apr 26. Here is FIND Diagnostics's employee count trend over the years:
Uncover FIND Diagnostics' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
FIND Diagnostics's Competitors and alternates
Top competitors of FIND Diagnostics include Adaptive Biotechnologies, MeMed and HaystackAnalytics. Here is the list of Top 10 competitors of FIND Diagnostics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Adaptive Biotechnologies 2009, Seattle (United States), Public | Provider of clinical diagnostics, and drug discovery for immune diseases | $419M | 72/100 | |
2nd | Provider of machine learning based diagnostic solutions for infectious diseases | $163M | 69/100 | ||
3rd |  HaystackAnalytics 2018, Mumbai (India), Seed | Provider of genomics technology for personalized clinical decisions | $17.3M | 66/100 | |
4th | Inflammatix 2016, San Francisco (United States), Series E | Provider of diagnostic solutions for systemic infections | $191M | 64/100 | |
5th |  Karius 2014, Redwood City (United States), Series C | Provider of diagnostics for identifying infectious diseases using microbial DNA | $315M | 58/100 | |
6th | Clear Labs 2014, Menlo Park (United States), Series D | Provider of food safety technologies for the identification of pathogens | $171M | 57/100 | |
7th | Seegene Technologies 2000, Seoul (South Korea), Acquired | Developer of molecular diagnostic kits to detect infectious and genetic diseases | - | 57/100 | |
8th | Developer of diagnostic solutions for sepsis and acute infections | $92.5M | 56/100 | ||
9th | Quantamatrix 2010, Seoul (South Korea), Public | Multiplexed platform for disease daignosis | $198K | 55/100 | |
10th |  T2 Biosystems 2006, Lexington (United States), Public | Developer of miniaturized MRI platforms for clinical diagnostics | $454M | 55/100 | |
72nd | FIND Diagnostics 2003, Geneva (Switzerland), Funding Raised | Diagnostic tests for poverty-related diseases | - | 36/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on FIND Diagnostics's competitors? Click here to see the top ones
FIND Diagnostics's Investments and acquisitions
FIND Diagnostics has made no investments or acquisitions yet.
News related to FIND Diagnostics
Filter this list•
Curetis, FIND Extend Antimicrobial Resistance Research CollaborationGenomeWeb•Aug 04, 2023•Curetis, FIND Diagnostics
•
OpGen’s Subsidiary Curetis and FIND Extend R&D Collaboration AgreementGlobeNewswire•Aug 03, 2023•OpGen, Curetis, FIND Diagnostics
•
•
•
FIND and VIA Global Health expand access to diagnosticsPharmaTimes•May 17, 2023•VIA Global Health, FIND Diagnostics
•
OpGen’s Subsidiary Curetis Meets All Remaining Key Milestones in R&D Collaboration with FINDGlobeNewswire•Apr 27, 2023•FIND Diagnostics, OpGen
•
OpGen’s Subsidiary Curetis Signs Expansion of R&D Collaboration with FINDGlobeNewswire•Apr 05, 2023•FIND Diagnostics, OpGen
•
•
Qlife receives milestone payment of 1.23 M USD from FINDCision•Jun 27, 2022•FIND Diagnostics, Qlife Holding
•
42 Technology and partners fast-track child TB diagnostic for WHOBusiness Weekly•Nov 30, 2021•42T, FIND Diagnostics, Rutgers
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about FIND Diagnostics
Explore our recently published companies
- Acemartech - 2020 founded, Unfunded company
- TreSkin - Grand Rapids based, 2007 founded, Unfunded company
- Mean and Green Microgreens - United States based, 2020 founded, Unfunded company
- Prashanti Sarees - Chennai based, 2016 founded, Unfunded company
- edXtra Tech - Nashik based, 2025 founded, Unfunded company
- CintaMedtech - 2019 founded, Unfunded company
